Mersana Therapeutics, Inc. Stock Prediction and Forecast [MRSN]

AI-generated source summary

Mersana Therapeutics (MRSN) shows mixed signals. While short-term and long-term moving averages suggest a bullish outlook, recent analyst ratings are mixed, with some initiating a 'Buy' and others an 'Underperform' or 'Sell' rating. The stock's recent surge of over 241% from a pivot bottom on November 6, 2025, indicates strong upward momentum. However, the stock's high daily movements and RSI of 87 suggest significant risk. Support levels are identified at $11.25 and $9.64, with breaks below these levels potentially signaling sell signals. The stock's price-to-earnings ratio of -0.600 suggests negative earnings, and the overall trend remains uncertain, with a 'Hold/Accumulate' recommendation.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   14 Nov 2025, 04:04 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

4. Live evaluation in progress

   01 Aug 2026, 02:15 UTC

   1 signal remains active.